SPaeDD-UK: Smart Paediatric Drug Development - UK Accelerating paediatric formulation development
An open innovation R&D project -
The ambition of the Consortium is to establish an industry standard framework and suite of tools to develop safe and efficacious paediatric dosage forms:
An overview of the program has recently been presented at the 8th EuPFI meeting in Portugal on 21st / 22nd September, 2016 and is available to download below
- Taste evaluation
- Acceptability testing
- Prediction of human exposure in children
- Technology platforms for paediatric medicines
An overview of the program has recently been presented at the 8th EuPFI meeting in Portugal on 21st / 22nd September, 2016 and is available to download below
| eupfi_lisbon_2016_overview_final.pdf |
This project will be primarily focussed on creating a development pathway comprising a tool box of testing methodologies (in-vitro, in-vivo and in-silico techniques) for predicting taste, drug release and human exposure in paediatric patients. The project is co-funded by Innovate UK, the UK's innovation agency.
These tools will be used to select the most appropriate formulations to support the development and commercialisation of paediatric pharmaceutical products. It is anticipated that the outputs of the project will be leveraged by a exploitation partner who will provide a commercially available service to appropriately evaluate, using the knowledge generated and develop paediatric dosage forms.
These tools will be used to select the most appropriate formulations to support the development and commercialisation of paediatric pharmaceutical products. It is anticipated that the outputs of the project will be leveraged by a exploitation partner who will provide a commercially available service to appropriately evaluate, using the knowledge generated and develop paediatric dosage forms.
